Sort
141,003 grants matching “cytokine”
Elucidating the neuroimmune mechanisms underlying pain and inflammation in autoimmune arthritis
$742,426Aakanksha Jain · University Of Washington · R00 · FY2025 · AR
The role of the innate immune system on Treg reprogramming in human autoimmune di
$742,405David A. Hafler · Yale University · U01 · FY2015 · AI
Follistatin-like protein 1 in cardiac and systemic metabolism
$742,374Fabio A Recchia · Temple Univ Of The Commonwealth · R01 · FY2017 · HL
Role of Gut Microbial Dysbiosis and Aging on HIV-associated neurocognitive and brain dysfunction
$742,372Shirish S Barve · University Of Louisville · R01 · FY2022 · AG
Hemolysis and Free Heme Signaling in Pulmonary Hypertension
$742,328Ruslan Rafikov · Indiana University Indianapolis · R01 · FY2024 · HL
Hemolysis and Free Heme Signaling in Pulmonary Hypertension
$742,328Ruslan Rafikov · Indiana University Indianapolis · R01 · FY2025 · HL
Dual drug delivery to lung/blood interface in respiratory infections.
$742,310Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2021 · HL
Augmented Transgenic TCR-mediated tumor therapy
$742,305Aude Chapuis · University Of Washington · P01 · FY2025 · CA
Persistent HIV expression induced type I IFN responses and inflammaging
$742,299Suryaram Gummuluru · Boston University Medical Campus · R01 · FY2020 · AG
Effective Therapies for Ocular Injuries by Vesicating Agents
$742,289Rajesh Agarwal · University Of Colorado Denver · U01 · FY2015 · EY
The NYU Women's Health Study
$742,259Anne Zeleniuch-Jacquotte · New York University School Of Medicine · UM1 · FY2016 · CA
Developing a Multi-epitope Pan-Coronavirus Vaccine
$742,241Lbachir Benmohamed · University Of California-Irvine · R01 · FY2023 · AI
Developing Evidence To Inform Regulatory Policy On Nicotine Content In E-Liquids
$742,204Risa Jean Robinson · Rochester Institute Of Technology · R01 · FY2025 · DA
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
$742,194Alexander Misharin · Northwestern University At Chicago · R01 · FY2022 · HL
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
$742,194Alexander Misharin · Northwestern University At Chicago · R01 · FY2023 · HL
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
$742,178Richard P Sloan · Columbia University Health Sciences · R01 · FY2011 · HL
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$742,154Arash Grakoui · Emory University · R01 · FY2021 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$742,132Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Engineering personalized micro-tumor ecosystems
$742,092Shiladitya Sengupta · Brigham And Women'S Hospital · U01 · FY2020 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
DARC, Inflammaging and Alzheimer's Disease
$741,989Xin-Yun Lu · Augusta University · R01 · FY2025 · AG
Anti-inflammatory signals and neurodegeneration
$741,976Bruno Conti · San Diego Biomedical Research Institute · R01 · FY2024 · NS
Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction
$741,975Rebecca Ashare · University Of Pennsylvania · R01 · FY2020 · DA
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$741,942Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function
$741,926Joseph De Rutte · Partillion Bioscience Corporation · R44 · FY2024 · GM